Jinhai Medical Tech Appoints New Chief Marketing Officer to Drive Commercial Strategy

Stock News08-03

Jinhai Medical Technology Co., Ltd. has announced a key executive appointment to strengthen its commercial operations. Mr. Ma Chengdong has been appointed as the group's new Chief Marketing Officer, effective August 3, 2026, for an initial term of one year. His role will encompass overseeing the marketing strategy, market access, academic promotion, and sales and channel operations for the company's products. In addition, he will be responsible for supervising the commercialization of the group's medical devices and equipment.

This strategic move aims to bolster Jinhai Medical Technology (02225) product launch efforts and market penetration. The appointment is set to take effect at the beginning of the third quarter of 2026.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment